Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Immortal Style: Closet Staples for Each Age - 2Ford Is Using a Chinese-Built Van to Fight Europe’s EV Price War
- 3Step by step instructions to Figure out the Natural Effect of 5G Pinnacles
- 4CDC pauses dozens of types of lab testing during evaluation and in wake of downsizing
- 5Vote in favor of Your #1 Instructive Toy: Learning and Tomfoolery Joined
- Internet goes (cocoa) nuts: The funniest reactions to 12 tonne theft of KitKat bars
- The Leonid meteor shower is peaking early this week. Here’s what to know
- The Force of Care: Living with Goal
- Down to earth Manual for A Modest Hyundai Ioniq Electric for Seniors
- Top 20 Compelling Business Books for Progress
- Get Cooking: 15 Speedy and Heavenly Recipes for Occupied Individuals
- Iran fires one of largest barrages in weeks ahead of Passover
- Vote in favor of your Favored Travel Movement
- Picking the Right Doctor prescribed Medication Inclusion in Senior Protection.
